SEARCH RESULT

Total Matching Records found : 76

Processed milk scare persists-GS Mudur

-The Telegraph A government laboratory has detected cancer-causing fungal toxins exceeding safety limits in samples of ultra-high-temperature processed milk, suggesting that a contamination problem highlighted eight years ago remains unresolved. Scientists at the Central Food Technological Research Institute (CFTRI), Mysore, have found a compound called aflatoxin M1, a fungal product labelled a carcinogen, in about 20 per cent of the samples of UHT milk they examined. Earlier studies in India over the past...

More »

Natco targets drugs ripe for compulsory licensing-Viswanath Pilla

-Live Mint Natco Pharma Ltd, which has started selling a generic version of Bayer AG’s patented cancer treatment Nexavar in India at a fraction of the price charged by the German firm, plans to use the so-called compulsory licensing route to try and win the right to copy more patented drugs, said vice-chairman and chief executive officer Rajeev Nannapaneni. The Hyderabad-based company has already identified the patented drugs for which it will...

More »

Cancer to be one of the deadliest diseases of the coming decades: Lancet-Divya Rajagopal

-The Economic Times It is not malaria or TB that will be the cause of large number of deaths in the world, Cancer is on its way to become one the deadliest diseases in the coming decades, according to a research paper published in medical journal Lancet. The study lead by Dr Freddy Bay of International Agency for Research on Cancer, France,predicts that the number of cancer patients in the world is...

More »

How PH Kurien took on global patents system to make very costly drug affordable for poor-Arvind Panagariya

It is said that only God and a few good men and women run India. One such man is P H Kurien. For readers unfamiliar with his name, Kurien was India's Controller General of Patents, Designs & Trade Marks until March 12, 2012. On March 9, 2012, just three days before he left office, he issued the first-ever compulsory licence in India for the manufacture of a drug still under patent....

More »

Doc panel for drug approval

-The Telegraph The Centre today asked a panel of doctors to outline measures to improve drug approval procedures, three days after a parliamentary standing committee said India’s drug regulators had broken laws, ignoring the interests of patients. The panel announced by the Union health ministry has been asked to suggest steps to improve the procedural aspects of the Central Drugs Standards Control Organisation (CDSCO), the agency entrusted with approving medicines for sale...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close